drugset / Trial / NCT00931723
Adult Bipolar Mania
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if lithium 600-1800 mg/day is effective when added to quetiapine fumarate extended release (quetiapine XR or SEROQUEL® XR) 400-800 mg/day in treating acute mania and if so, how it compares with placebo (a non-active capsule, like a sugar pill, that looks like lithium).
Timeline
- Start
- 2009-06
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lithium | Unknown | 900 mg | Oral |
| Comparator | Quetiapine | Small molecule | 600 mg | Oral |